Polymorphisms of dopamine D2-like (D2, D3, and D4) receptors in schizophrenia. 1996

K Ohara, and Y Nakamura, and D W Xie, and T Ishigaki, and Z L Deng, and K Tani, and H Y Zhang, and N Kondo, and J C Liu, and K Miyasato, and K Ohara
Department of Psychiatry, Hamamatsu University School of Medicine, Shizuoka, Japan.

The result of most association studies and linkage analyses have suggested a negative association between schizophrenia and D2-like (D2, D3, and D4) receptor polymorphisms. Although the polymorphisms of the D2-like receptor in themselves may not account for the etiology of schizophrenia, they can contribute to the severity of the symptoms. Thus, we studied the associations between the polymorphisms and their combinations, and the vulnerability of schizophrenics. Fragments of the D2-like receptor genes were amplified by means of the polymerase chain reaction, and the polymorphisms were identified by the restriction fragment length polymorphism and single-stranded conformation polymorphism methods. There were no statistically significant differences in the polymorphisms and their combinations between schizophrenics and controls. Schizophrenics with D4E1(A1/A2), which contains 2 and 1 tandem repeats of a 12-base-pair sequence in exon 1, had a lower total positive symptom score before medication than schizophrenics with D4E1(A1/A1). There was no association between the polymorphisms and negative symptoms.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph

Related Publications

K Ohara, and Y Nakamura, and D W Xie, and T Ishigaki, and Z L Deng, and K Tani, and H Y Zhang, and N Kondo, and J C Liu, and K Miyasato, and K Ohara
April 1996, The Journal of pharmacology and experimental therapeutics,
K Ohara, and Y Nakamura, and D W Xie, and T Ishigaki, and Z L Deng, and K Tani, and H Y Zhang, and N Kondo, and J C Liu, and K Miyasato, and K Ohara
July 2004, Cell and tissue research,
K Ohara, and Y Nakamura, and D W Xie, and T Ishigaki, and Z L Deng, and K Tani, and H Y Zhang, and N Kondo, and J C Liu, and K Miyasato, and K Ohara
March 1994, Psychiatry research,
K Ohara, and Y Nakamura, and D W Xie, and T Ishigaki, and Z L Deng, and K Tani, and H Y Zhang, and N Kondo, and J C Liu, and K Miyasato, and K Ohara
May 1992, Biochemical Society transactions,
K Ohara, and Y Nakamura, and D W Xie, and T Ishigaki, and Z L Deng, and K Tani, and H Y Zhang, and N Kondo, and J C Liu, and K Miyasato, and K Ohara
September 1996, Journal of affective disorders,
K Ohara, and Y Nakamura, and D W Xie, and T Ishigaki, and Z L Deng, and K Tani, and H Y Zhang, and N Kondo, and J C Liu, and K Miyasato, and K Ohara
January 1995, Journal of receptor and signal transduction research,
K Ohara, and Y Nakamura, and D W Xie, and T Ishigaki, and Z L Deng, and K Tani, and H Y Zhang, and N Kondo, and J C Liu, and K Miyasato, and K Ohara
February 1996, Journal of neurochemistry,
K Ohara, and Y Nakamura, and D W Xie, and T Ishigaki, and Z L Deng, and K Tani, and H Y Zhang, and N Kondo, and J C Liu, and K Miyasato, and K Ohara
June 1995, European journal of pharmacology,
K Ohara, and Y Nakamura, and D W Xie, and T Ishigaki, and Z L Deng, and K Tani, and H Y Zhang, and N Kondo, and J C Liu, and K Miyasato, and K Ohara
May 1998, American journal of medical genetics,
K Ohara, and Y Nakamura, and D W Xie, and T Ishigaki, and Z L Deng, and K Tani, and H Y Zhang, and N Kondo, and J C Liu, and K Miyasato, and K Ohara
January 2008, Neuropsychobiology,
Copied contents to your clipboard!